Vasculogenic MSC: An Innovative Stem Cell Approach for Vascular and Circulatory Health — Who Is It Suitable For, and How Often Should It Be Done?

Vasculogenic MSC is a type of stem cell, or Mesenchymal Stem Cell, with the potential to develop into cells involved in the formation or support of blood vessels, such as endothelial cells and pericytes. These cells play an important role in the formation and maintenance of tissues, including organs related to the circulatory system such as the heart, brain, kidneys, and most organs in the body that depend on blood vessels for their blood supply.

Vasculogenic MSC has several properties that may help support vascular-system recovery, including:

• Supports vascular-function recovery: Helps repair blood vessels that have deteriorated or become damaged, supporting better balance and function of the circulatory system and helping reduce disease severity.
• Stimulates new blood-vessel formation: Vasculogenic MSC can stimulate angiogenesis, helping support the formation of new blood vessels so that tissues can receive more oxygen and nutrients.
• Helps improve blood circulation: When the vascular system functions more efficiently, blood can circulate more effectively to important organs such as the brain, heart, and muscles, contributing positively to overall health.
• Supports recovery of tissues related to the vascular system: By stimulating the repair of tissues damaged by different factors, it may help slow the degeneration of vascular cells.

• Intravenous administration of Vasculogenic MSC (IV Drip) helps stimulate the body's natural vascular and circulatory recovery processes. It may support recovery after vascular disease and help slow long-term degeneration of the circulatory system.
• Helps support the function of important organs that depend on the vascular system, such as the heart, kidneys, and brain, contributing positively to overall health.
• Vasculogenic MSC by IV Drip is a relatively straightforward procedure that takes approximately 20-30 minutes. Afterward, patients can return to their normal daily activities without needing to recover at the clinic.
• Vasculogenic MSC derived from umbilical-cord tissue has a favorable safety profile and tends to have low immunogenicity because the cells are at an early stage of life and have less cellular damage compared with cells derived from adult tissues. The cells also undergo strict donor screening and quality-control procedures in a standardized laboratory.
• It can be combined with other medical treatments or health-recovery approaches to further support vascular and circulatory recovery. However, this approach should be performed only under close supervision by an experienced physician.

• Responses and results after the procedure may vary depending on several factors, including age, severity of the condition, other underlying diseases, and individual self-care.
• Vasculogenic MSC is only an approach intended to support recovery of the vascular and circulatory systems and help them function more effectively. It is not a treatment for disease and cannot replace standard medical treatment.
• The procedure must be carried out under the supervision of an experienced physician with strict quality control at every stage, including physical-readiness assessment, quality of the cells used, method of cell administration, and post-treatment follow-up.
• Vasculogenic MSC performed in a standard-compliant clinic by an experienced physician is considered a safe procedure. However, temporary side effects may occur, such as pain or swelling at the cell-administration site, fatigue, or low-grade fever. In general, these symptoms resolve naturally within 1-3 days.

In general, administration of Mesenchymal Stem Cells, including Vasculogenic MSC, is considered a safe process when performed under the supervision of an experienced physician and when the selected cells have undergone strict quality control, contamination testing, and safety assessment regarding risks such as tumor or cancer formation.

However, Stem Cell therapy is still considered a Regenerative Medicine approach that requires continued study. Therefore, anyone interested should undergo a detailed health assessment before treatment to ensure that the approach is appropriate and safe for the individual.

Before Receiving Vasculogenic MSC

• Consult a physician for a physical assessment before treatment. The physician will review health history, underlying conditions, and perform blood tests as appropriate for each case.
• Get sufficient rest, at least 6-8 hours, to prepare the body.
• Drink enough clean water and eat nutritious foods.
• Avoid alcohol and smoking for at least 1 week.
• Take care to avoid injury, physical impact, or wounds. Avoid other procedures such as Filler injections, Bo programs, liposuction, or laser treatments for at least 1-2 weeks.

After Receiving Vasculogenic MSC

• Get adequate rest during the first 1-2 days.
• Drink more clean water to help the body recover.
• Avoid strenuous exercise during the first 24-48 hours.
• Avoid injury, wounds, abrasions, or physical impact to the area where the cells were administered for at least 2 weeks.
• Avoid smoking and alcohol for at least 1 week.
• Attend follow-up appointments with the physician as scheduled. If any abnormal symptoms occur, seek medical attention immediately.